Clinical Trials Browser

INDUSTRY × Nivolumab × Plasma cell × Clear all

NCT02719613 2025-06-05

Continuing Treatment for Participants Who Have Participated in a Prior Protocol Investigating Elotuzumab

Phase 2 Active not recruiting

Multiple Myeloma

NCT02726581 2023-03-27

CheckMate 602

Phase 3 Completed

170 enrolled 16 charts

Multiple Myeloma